{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:12:26Z","timestamp":1793653946228,"version":"4.5.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.neuropharm.2019.107838","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T13:01:02Z","timestamp":1572786062000},"page":"107838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6464-4831","authenticated-orcid":false,"given":"Anna U.","family":"Odland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-1267","authenticated-orcid":false,"given":"Jesper L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-4541","authenticated-orcid":false,"given":"Ciar\u00e1n M.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-4990","authenticated-orcid":false,"given":"Jesper T.","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107838_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0026-895X(25)09149-7","article-title":"Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus","volume":"50","author":"Almaula","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib2","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/NDT.S62785","article-title":"Animal models of obsessive\u2013compulsive disorder: utility and limitations","volume":"11","author":"Alonso","year":"2015","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2019.107838_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/aur.1395","article-title":"Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf\/J mice","volume":"7","author":"Amodeo","year":"2014","journal-title":"Autism Res. : Off. J. Int. Soc. Autism Res."},{"key":"10.1016\/j.neuropharm.2019.107838_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/gbb.12343","article-title":"5HT(2A) receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice","volume":"16","author":"Amodeo","year":"2017","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2019.107838_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2015.01.001","article-title":"Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action","volume":"1601","author":"Andreasen","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107838_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.eatbeh.2015.12.008","article-title":"Contributions of cognitive inflexibility to eating disorder and social anxiety symptoms","volume":"21","author":"Arlt","year":"2016","journal-title":"Eat. Behav."},{"key":"10.1016\/j.neuropharm.2019.107838_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2013.02.038","article-title":"Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway","volume":"247","author":"Arora","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107838_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib9","series-title":"The Design and Statistical Analysis of Animal Experiments","author":"Bate","year":"2014"},{"key":"10.1016\/j.neuropharm.2019.107838_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/mol.53.4.649","article-title":"Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (\"Ecstasy\") in serotonin transporter-deficient mice","volume":"53","author":"Bengel","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib11","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm000339w","article-title":"Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines","volume":"43","author":"Blair","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2019.107838_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib13","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","article-title":"Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats","volume":"33","author":"Boulougouris","year":"2008","journal-title":"Neuropsychopharmacology : Off. Publ. Am. Coll. Neuropsychopharmacol.."},{"key":"10.1016\/j.neuropharm.2019.107838_bib14","first-page":"1955","volume":"vol. 20","author":"Brigman","year":"2010"},{"key":"10.1016\/j.neuropharm.2019.107838_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphar.2018.00017","article-title":"Tolerance and tachyphylaxis to head twitches induced by the 5-HT2A agonist 25CN-NBOH in mice","volume":"9","author":"Buchborn","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"The Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2019.107838_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107838_bib18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/0269881111420313","article-title":"A comparison of InVivoStat with other statistical software packages for analysis of data generated from animal experiments","volume":"26","author":"Clark","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1248\/bpb.35.376","article-title":"Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice","volume":"35","author":"Egashira","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2019.107838_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-014-3739-3","article-title":"Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT(2A) receptors, in mice","volume":"232","author":"Fantegrossi","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.euroneuro.2015.12.003","article-title":"Compulsivity in obsessive-compulsive disorder and addictions","volume":"26","author":"Figee","year":"2016","journal-title":"Eur. Neuropsychopharmacol. : J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/11591790-000000000-00000","article-title":"Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments","volume":"71","author":"Fontenelle","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2019.107838_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S1461145711001441","article-title":"5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats","volume":"15","author":"Furr","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00289","article-title":"Hippocampal 5-HT1A receptor and spatial learning and memory","volume":"6","author":"Glikmann-Johnston","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/npp.2009.29","article-title":"5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice","volume":"34","author":"Halberstadt","year":"2009","journal-title":"Neuropsychopharmacology : Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2015.08.008","article-title":"Transdiagnostic mechanisms in depression and anxiety: the role of rumination and attentional control","volume":"188","author":"Hsu","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2019.107838_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.117.239905","article-title":"Detailed characterization of the in vitro pharmacological and pharmacokinetic properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a highly selective and brain-penetrant 5-HT2A receptor agonist","volume":"361","author":"Jensen","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.107838_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","article-title":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","volume":"189","author":"Krebs-Thomson","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib31","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.neuropharm.2019.107838_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acschemneuro.5b00023","article-title":"Cartography of 5-HT1A and 5-HT2A receptor subtypes in prefrontal cortex and its projections","volume":"6","author":"Mengod","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107838_bib33","first-page":"364","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","author":"Moda-Sava","year":"2019","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.neuropharm.2019.107838_bib34","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107838_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00213-014-3699-7","article-title":"Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia","volume":"232","author":"Navarro","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.107838_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as medicines: an emerging new paradigm","volume":"101","author":"Nichols","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.107838_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1476-5381.1991.tb12392.x","article-title":"Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents","volume":"104","author":"Njung'e","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib40","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1021\/acschemneuro.8b00593","article-title":"8-OH-DPAT induces compulsive-like deficit in spontaneous alternation behavior: reversal by MDMA but not citalopram","volume":"10","author":"Odland","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107838_bib41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jnc.14227","article-title":"16p11.2 deletion syndrome mice perseverate with active coping response to acute stress - rescue by blocking 5-HT2A receptors","volume":"143","author":"Panzini","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.107838_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2013.01.005","article-title":"5-HT2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorder","volume":"243","author":"Papakosta","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107838_bib43","doi-asserted-by":"crossref","first-page":"20140873","DOI":"10.1098\/rsif.2014.0873","article-title":"Homological scaffolds of brain functional networks","volume":"11","author":"Petri","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.neuropharm.2019.107838_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00443425","article-title":"Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex","volume":"97","author":"Pierce","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2005.07.013","article-title":"Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice","volume":"166","author":"Ripoll","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107838_bib46","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/sj.npp.1301161","article-title":"Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice","volume":"31","author":"Risbrough","year":"2006","journal-title":"Neuropsychopharmacology : Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107838_bib47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s002130050819","article-title":"Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor","volume":"141","author":"Scearce-Levie","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.107838_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2018.05.031","article-title":"Enhanced central histaminergic transmission attenuates compulsive-like behavior in mice","volume":"138","author":"Verma","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107838_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0091-3057(91)90559-K","article-title":"Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder?","volume":"40","author":"Yadin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:09:31Z","timestamp":1758438571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819304046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":51,"alternative-id":["S0028390819304046"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107838","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107838"}}